Baby Safety / Compounds / Carisoprodol (Soma)

Is Carisoprodol (Soma) safe for babies and kids?

Very high risk for kids

Infants are more vulnerable to Carisoprodol (Soma) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is carisoprodol (soma)?

The IUPAC name is [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate.

Also known as: [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate, carisoprodol, Isomeprobamate, Carisoprodate.

IUPAC name
[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate
CAS number
78-44-4
Molecular formula
C12H24N2O4
Molecular weight
260.33 g/mol
SMILES
CCCC(C)(COC(=O)N)COC(=O)NC(C)C
PubChem CID
2576

Risk for babies

Very high risk

Infants are more vulnerable to Carisoprodol (Soma) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Carisoprodol (Soma), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

2 regulatory and scientific bodies have classified Carisoprodol (Soma). The classifications differ — that's the data.

AgencyYearClassificationNotes
EPA CTX / Genetox—Genotoxicity: negative (Ames: negative, 0 positive / 2 negative reports)
EPA CTX / Genetox—Genotoxicity: negative (Ames: negative, 0 positive / 2 negative reports)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter carisoprodol (soma)

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Carisoprodol (Soma):

  • Therapeutic alternatives (consult prescriber)
    Trade-offs: Drug-specific. Cannot substitute without medical guidance.
    Relative cost: 1.2-2×

Frequently asked questions

Is carisoprodol (soma) safe for kids?

Infants are more vulnerable to Carisoprodol (Soma) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain carisoprodol (soma)?

Carisoprodol (Soma) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to carisoprodol (soma)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Carisoprodol (Soma) in the baby app

Look up products containing carisoprodol (soma), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (2)
  1. US DEA: Carisoprodol (Soma) — Schedule IV Classification (2012), Meprobamate Metabolite Mechanism, 'Soma Coma' Polysubstance Abuse Combination, Withdrawal Seizure Risk, and Prescribing Patterns in Southern US States (2022) (2022) — regulatory
  2. US FDA: Carisoprodol — Prescribing Information, 2–3 Week Maximum Duration, Meprobamate Hepatic Metabolism, Physical Dependence and Withdrawal, Schedule IV Controlled Status, and Pediatric Contraindication (<16 Years) (2022) (2022) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →